Related Experiment Video
Updated: Nov 14, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
When adherence and inhalation technique matter: Difficult-to-control pediatric asthma in low- to middle-income
Carlos E Rodriguez-Martinez1,2, Monica P Sossa-Briceño3, Ian P Sinha4
1Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.
Insights
Many children with asthma struggle to control their condition due to poor adherence and inhaler technique. Simple, cost-effective tools can help assess and improve medication use in pediatric asthma management.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Global Health
Background:
- Asthma control remains a challenge for many pediatric patients, particularly in low- and middle-income countries (LMICs).
- Poor adherence to inhaled corticosteroids (ICS) and incorrect inhaler technique are primary modifiable factors contributing to uncontrolled asthma.
- High costs and limited availability of electronic monitoring devices restrict their use in identifying severe asthma.
Purpose of the Study:
- To identify cost-effective alternatives for assessing adherence and inhaler technique in pediatric asthma.
- To provide clinicians with practical strategies to improve controller therapy use in children.
- To reduce reliance on expensive treatments and optimize resource allocation in LMICs.
Main Methods:
- Review of current challenges in pediatric asthma management.
- Exploration of validated self-reported questionnaires for adherence assessment.
- Consideration of inhaler canister weight as an adherence indicator.
- Emphasis on validated instruments for evaluating inhaler technique.
Main Results:
- Validated self-reported questionnaires and inhaler canister weight offer practical alternatives to electronic monitoring for assessing adherence.
- Validated instruments can objectively measure inhaler technique adequacy.
- Recognizing adherence issues is a crucial first step toward improving compliance.
Conclusions:
- Clinicians can utilize accessible tools to assess and improve adherence and inhaler technique in pediatric asthma patients.
- Optimizing the use of inhaled corticosteroids (ICS) can prevent unnecessary escalation of therapy and reduce healthcare costs.
- These strategies support rational and cost-effective asthma management, especially in resource-limited settings.
Abstract:
Despite relatively recent advances in our understanding of the physiopathology of asthma and the availability of highly effective controller medications, such as inhaled corticosteroids (ICS), currently many pediatric patients fail to control their asthma, especially in low- and middle-income countries (LMICs). Although some of these difficult-to-control asthmatic children have severe therapy-resistant asthma, most of them experience poor asthma control due to various modifiable factors, among which poor adherence to inhaled controller therapy and inadequate inhaler technique are the most common. Although electronic monitoring devices have been considered to be essential tools in identifying patients with severe therapy-resistant asthma, their high cost and low availability have currently limited their use in clinical practice. For these reasons, clinicians might consider using validated self-reported questionnaires and the weight of inhaler canisters and as alternative and valid options for assessing adherence to inhaled controller therapy. Furthermore, clinicians might consider adopting validated instruments as an objective measurement of the adequacy of inhaler technique. Although recognizing poor adherence does not automatically lead to improved adherence, it is usually an essential first step in effectively targeting adherence behavior, especially if the reasons for low or erratic compliance are explored by means of non-judgmental doctor-patient communication. These recommendations could assist in overcoming our inability to have pediatric asthmatic patients use ICS and in avoiding escalating their controller therapy toward more expensive medications, eventually reaching the use biologics. Promoting the rational and cost-effective use of asthma controller therapy could help to optimize the limited health resources in many LMICs.
More Related Videos
04:21A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
Published on: August 4, 2021
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation